Title : Inhibition of PC-3 prostate cancer cell growth in vitro using both antisense oligonucleotides and taxol.

Pub. Date : 2003

PMID : 12665682






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Antisense oligonucleotides (oligos) directed against mRNA-encoding transforming growth factor-alpha (TGF-alpha) and the epidermal growth factor receptor (EGFR) have demonstrated in vitro and in vivo efficacy against prostate cancer tumor models. Oligonucleotides epidermal growth factor receptor Homo sapiens
2 Antisense oligonucleotides (oligos) directed against mRNA-encoding transforming growth factor-alpha (TGF-alpha) and the epidermal growth factor receptor (EGFR) have demonstrated in vitro and in vivo efficacy against prostate cancer tumor models. Oligonucleotides epidermal growth factor receptor Homo sapiens
3 Antisense oligonucleotides (oligos) directed against mRNA-encoding transforming growth factor-alpha (TGF-alpha) and the epidermal growth factor receptor (EGFR) have demonstrated in vitro and in vivo efficacy against prostate cancer tumor models. Oligonucleotides epidermal growth factor receptor Homo sapiens
4 Antisense oligonucleotides (oligos) directed against mRNA-encoding transforming growth factor-alpha (TGF-alpha) and the epidermal growth factor receptor (EGFR) have demonstrated in vitro and in vivo efficacy against prostate cancer tumor models. Oligonucleotides epidermal growth factor receptor Homo sapiens